Adagio Medical Holdings, Inc. (ADGM)
NASDAQ: ADGM · Real-Time Price · USD
3.420
+0.060 (1.79%)
Sep 26, 2024, 4:00 PM EDT - Market closed
Adagio Medical Holdings Revenue
Adagio Medical Holdings had revenue of $254.00K in the quarter ending June 30, 2024. This brings the company's revenue in the last twelve months to $399.00K. In the year 2023, Adagio Medical Holdings had annual revenue of $300.00K with 58.73% growth.
Revenue (ttm)
$399.00K
Revenue Growth
+58.73%
P/S Ratio
6.60
Revenue / Employee
$4,694
Employees
85
Market Cap
45.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 300.00K | 111.00K | 58.73% |
| Dec 31, 2022 | 189.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionADGM News
- 5 weeks ago - Adagio Medical Provides Business Updates - Business Wire
- 2 months ago - Adagio Medical Announces the Closing of the Business Combination with ARYA IV, Creating a Publicly Traded Company Focused on the Innovative Technologies for Treatment of Cardiac Arrhythmias - Business Wire
- 8 months ago - Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies - PRNewsWire
- 2 years ago - ARYA Sciences Acquisition Corp IV and Amicus Therapeutics, Inc. Mutually Agree to Terminate Business Combination Agreement With Respect to the Acquisition of Amicus' Gene Therapy Business Due to Market Conditions - GlobeNewsWire